Dave Collins is the COO of BNI Global, the global leader in b2b networking and referrals with over $22 billion in closed referrals shared in the last year.With 37 years in the real estate industry and senior leadership experience, David has built his career around one core belief: relationships drive revenue when they’re structured with discipline and intent.Today, Dave helps lead global growth for BNI across 76 countries. His focus is simple, amplify the brand, strengthen chapters, and help business owners treat referrals as a system, not luck.He believes BNI works best when it’s approached like a true marketing channel:• Show up consistently• Build real relationships• Track performance• Stay accountableTo Dave, BNI isn’t transactional. It’s transformational. He has seen firsthand how the right business community can change not only revenue outcomes, but leadership habits, confidence, and long-term vision.
Lizzy Livne is the founder and CEO of Quiet Lux, the modern concierge designed to make life lighter, smoother, and more beautiful. A military veteran who served in the Israel Defense Forces (IDF) and a Forbes 30 Under 30 honoree, Lizzy brings a rare blend of discipline, creativity, and strategic vision to everything she builds. A graduate of Northeastern University, Lizzy previously held roles at Morgan Stanley, OTV, and Samsung Next, experiences that sharpened her operational expertise and deepened her understanding of how people and systems function at scale.Quiet Lux specializes in the four pillars of modern living: life admin, life projects, lifestyle, and leisure. From managing calendars and handling logistics, to overseeing home projects, to curating travel, dining, and cultural experiences, Lizzy and her team bring structure and elegance to the everyday by ensuring clients have the space to focus on what truly matters to them.
Dr. Michael Weickert is a biopharmaceutical CEO, scientist, and author with more than 30 years of experience at the intersection of drug development, commercial strategy, and healthcare innovation. Throughout his career, he helped translate scientific discoveries into clinical programs and investor- and partner-ready products. That experience drives his work today: why do some breakthrough healthcare innovations never reach the patients who need them and what can we do about it?As Chief Executive Officer of Pacylex Pharmaceuticals, Dr. Weickert has led the company’s strategic and financial direction, securing approximately $23 million in seed, Series A, and bridge financing and advancing multiple oncology programs to Phase 2 readiness, including achieving Orphan Drug and Fast Track designations for its lead asset. As CEO of Fe Pharmaceuticals, he has led a strategic transformation of the organization, strengthening executive leadership, expanding scientific advisory capabilities, securing early-stage funding and non-dilutive grants, and building successful collaborations with NIAID.Across previous CEO and C-suite roles, Dr. Weickert has built and scaled biotechnology and medical technology organizations through critical stages of growth, including company formation, fundraising, clinical development, regulatory strategy, strategic partnerships, and commercialization. His career includes leadership roles at organizations such as Nektar Therapeutics, Ligand Pharmaceuticals, and other emerging life sciences companies, where he led cross-functional teams, advanced novel therapeutic programs, and helped bring scientific innovation closer to patient impact.In addition to his executive leadership roles, Dr. Weickert serves as an advisor to Stanford University School of Medicine’s SPARK Translational Research Program, supporting researchers as they translate academic discoveries into practical therapeutics and diagnostics. Through his writing and public commentary, he examines the scientific, economic, and systemic forces that influence which medical breakthroughs reach patients—and which do not.
Following the eBook launch (One Network, One Truth), we have invited Michael Schlagel to talk about it broadly.Michael Schlagel is the VP of Sales Americas Telecoms at VertiGIS, where he helps customers across various industries leverage the power of geographic information systems (GIS) to optimize their operations, enhance their decision-making, and improve their bottom line. With over 20 years of professional sales experience and 8 years of sales management experience, Michael has a proven record of increasing sales volume and market share, while delivering exceptional customer satisfaction.
In this Uncaged, we had Remy Scalza and Caroline Carter-Smith as guets. Both are co-founders of CSuite Content, an executive communications firm I established in 2015.This boutique agency works exclusively with CEOs and senior leaders on thought leadership and executive visibility — one of the first of its kind. Big companies find them when they’re ready to work with a highly specialized team of expert writers, thoughtful social media strategists, and trusted senior advisors who care intensely about results.Before founding CSuite Content, Remy built his career as a journalist, contributing to publications including The Washington Post, The New York Times, and The Globe and Mail. After years of interviewing executives across a wide range of industries, he recognized that many accomplished leaders struggled to communicate their ideas in a way that reflected their expertise and differentiated them from their peers. That insight led him to establish CSuite Content, where he has spent the past decade helping leaders at fast-growing startups, Fortune 500 companies, and global enterprises develop thought leadership programs that support business growth, strengthen executive visibility, and drive meaningful media opportunities.Before CSuite, Caroline worked in lifestyle and tech PR and spent time as a broadcast journalist, which gave her a low tolerance for jargon and a strong bias toward clarity. She is a compulsive strategist and always seeking out the most compelling narrative and story.